SEP 22, 2022 8:00 AM PDT

Clinical utility of digital PCR (dPCR) in liquid biopsy for the management of cancer

Sponsored by: Thermo Fisher Scientific
Speaker
  • Head of the Liquid Biopsy Laboratory at Hospital Universitario Puerta Hierro, Majadahonda, Spain
    BIOGRAPHY

Abstract
Date:  September 22, 2022
Time: 8:00am (PDT),  11:00am (EDT), 5:00pm (CEST)
 
Liquid biopsies used to identify and track genetic mutationsin cancer patinets, enabling researchers to detect cancer early, measure therapeutic response, quantify residual tumor burden, and monitor emerging resistance to therapies. Liquid biopsies utilize cell-free DNA (cfDNA) that is derived from cells, both normal and cancerous, that have undergone apoptosis or necrosis and released their DNA contents into their environment. The component of cfDNA that is released from cancer cells is more commonly referred to as circulating tumor DNA, or ctDNA. dPCR has enabled the development of liquid biopsy-based approaches.
 
Join Dr. Atocha Romero in this webinar to learn about the analysis of ctDNA by dPCR, which has several clinical applications:
 
1) ctDNA genotyping can be used for non-invasive biomarker testing, which is especially relevant in lung cancer patients in whom tissue biopsies are difficult to obtain due to the anatomical location of the tumors and the advanced age of the patients. In this sense, ctDNA genotyping may expand the life expectancy of some cancer patients who are unable to undergo an invasive procedure by the identification of therapeutic targets.
 
2) ctDNA levels correlate well with tumor bulk. Therefore, ctDNA quantification over the course of the treatment can be used for narrow tumor response to treatment monitoring, as well as for early detection of resistance mutations.
 
3) ctDNA levels are of prognostic significance as ctDNA levels have been shown to correlate well with survival outcomes. In this sense, ctDNA levels may be used as an early endpoint surrogate in clinical trials.
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
JUL 19, 2022 8:00 AM PDT
C.E. CREDITS
JUL 19, 2022 8:00 AM PDT
Date: July 19, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Cryo-EM is rapidly becoming the method of choice for structural biologists and biochemists around the world, helping thes...
MAR 29, 2022 9:00 AM PDT
C.E. CREDITS
MAR 29, 2022 9:00 AM PDT
Date: March 29, 2022 Time: 09:00am (PDT), 12:00pm (EDT), 17:00 (GMT) Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clin...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
Loading Comments...
Show Resources